Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18Mar-31-18
   10-Q10-Q10-KS-1/A10-Q10-Q
Revenues  0.00.00.00.00.00.0
Cost of goods sold  -2.00.00.01.11.11.1
Gross profit  2.00.00.0-1.1-1.1-1.1
Selling, general and administrative   [+]6.210.411.310.19.03.2
Research and development  1.11.11.10.90.70.5
Other operating expenses  0.4     
EBIT   [+]-5.8-11.5-12.4-10.8-9.6-3.6
Interest income  0.0     
Other income (expense), net   [+] 0.0    
Pre-tax income  -5.7-11.5-12.4-11.0-9.7-3.7
Income taxes  0.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -5.7-11.5-12.4-11.0-9.7-3.7
   
Basic EPS   [+]($0.62)($1.30)($1.44)($1.35)($1.31)($0.55)
Diluted EPS   [+]($0.62)($1.30)($1.44)($1.35)($1.31)($0.55)
   
Shares outstanding (basic)   [+]9.28.98.78.17.46.7
Shares outstanding (diluted)   [+]9.28.98.78.17.46.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy